1. Home
  2. AXDX vs NAII Comparison

AXDX vs NAII Comparison

Compare AXDX & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXDX
  • NAII
  • Stock Information
  • Founded
  • AXDX 1982
  • NAII 1980
  • Country
  • AXDX United States
  • NAII United States
  • Employees
  • AXDX N/A
  • NAII N/A
  • Industry
  • AXDX Biotechnology: Laboratory Analytical Instruments
  • NAII Medicinal Chemicals and Botanical Products
  • Sector
  • AXDX Industrials
  • NAII Health Care
  • Exchange
  • AXDX Nasdaq
  • NAII Nasdaq
  • Market Cap
  • AXDX 28.3M
  • NAII 26.0M
  • IPO Year
  • AXDX 1996
  • NAII 1987
  • Fundamental
  • Price
  • AXDX $1.19
  • NAII $4.05
  • Analyst Decision
  • AXDX Hold
  • NAII
  • Analyst Count
  • AXDX 1
  • NAII 0
  • Target Price
  • AXDX $1.00
  • NAII N/A
  • AVG Volume (30 Days)
  • AXDX 31.2K
  • NAII 4.9K
  • Earning Date
  • AXDX 03-27-2025
  • NAII 02-14-2025
  • Dividend Yield
  • AXDX N/A
  • NAII N/A
  • EPS Growth
  • AXDX N/A
  • NAII N/A
  • EPS
  • AXDX N/A
  • NAII N/A
  • Revenue
  • AXDX $11,909,000.00
  • NAII $121,853,000.00
  • Revenue This Year
  • AXDX $0.66
  • NAII N/A
  • Revenue Next Year
  • AXDX $3.36
  • NAII N/A
  • P/E Ratio
  • AXDX N/A
  • NAII N/A
  • Revenue Growth
  • AXDX N/A
  • NAII N/A
  • 52 Week Low
  • AXDX $0.73
  • NAII $4.02
  • 52 Week High
  • AXDX $2.09
  • NAII $7.26
  • Technical
  • Relative Strength Index (RSI)
  • AXDX 46.90
  • NAII 36.48
  • Support Level
  • AXDX $1.07
  • NAII $4.08
  • Resistance Level
  • AXDX $1.22
  • NAII $4.19
  • Average True Range (ATR)
  • AXDX 0.10
  • NAII 0.11
  • MACD
  • AXDX -0.01
  • NAII -0.01
  • Stochastic Oscillator
  • AXDX 41.38
  • NAII 8.76

About AXDX Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

Share on Social Networks: